The annual rankings from U.S. News are here, with some familiar names making the top of the list. Did your facility make the cut? 

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

The company has now raised $248M in total to help develop, commercialize and market its FDA-cleared technology. 

Former European Society of Cardiology president Prof. Jeroen Bax explains the difficulty in quantifying these plaques manually and how artificial intelligence may change this to allow rapid, detailed quantitative analysis. 

Mike Shapiro, DO, MD, director of the Center for Prevention of Cardiovascular Disease at Wake Forest University, discusses the current guidelines for computed tomography (CT) calcium scoring as a screening test to assess heart attack risk.

The 60-year-old cardiologist was facing up to 20 years in prison for his actions.